China
Africa
Explore chapters and articles related to this topic
Classifications
Published in Fazal-I-Akbar Danish, Ahmed Ehsan Rabbani, Pharmacology in 7 Days for Medical Students, 2018
Fazal-I-Akbar Danish, Ahmed Ehsan Rabbani
Drugs for unproductive coughPeripheral antitussivesDrugs with local anaesthetic activityBenzonatateDemulcentsLiquorice lozengesSteam inhalationWith tincture mentholCentral antitussivesOpioid antitussivesAddicting drugsDihydromorphinoneMethadoneMorphineNon-addicting drugsDihydrocodeinonePholcodineNon-opioid antitussivesBenzonatateCarbetapentaneChlorphedianolDextromethorphanNarcotineOxeladine
Bilateral pneumatoceles resulting in spontaneous bilateral pneumothoraces and secondary infection in a previously healthy man with COVID-19
Published in Baylor University Medical Center Proceedings, 2021
Piruthiviraj Natarajan, James Skidmore, Olufemi Aduroja, Vamsi Kunam, Dan Schuller
He returned 3 days later with oxygen saturations in the low 80s, worsening shortness of breath, myalgias, headache, and diarrhea. His temperature was 99.3 °F, blood pressure 122/79 mm Hg, heart rate 94 beats/minute, and respiratory rate 23 breaths/minute, with pulse oximetry 86% on ambient air. Laboratory results showed a white blood cell count of 5040/mm3, C-reactive protein of 21 mg/dL, lactate dehydrogenase of 688 units/L, fibrinogen of 719 mg/dL, and D-dimer of 2.5 mcg/mL. Computed tomography (CT) of the chest was negative for pulmonary embolus but revealed typical COVID-19 pneumonia changes (Figure 1a). The patient was placed on an Oxymizer at 15 L to keep his oxygen saturation above 92% and was admitted to the intensive care unit, where he received intravenous (IV) remdesivir 200 mg on day 1 and 100 mg on days 2 to 4; two doses of the anti–IL-6 monoclonal antibody tocilizumab 400 mg IV; dexamethasone 6 mg IV daily; azithromycin 500 mg IV piggyback daily; a unit of COVID-19 convalescent plasma transfusion; and subcutaneous enoxaparin 40 mg every 12 hours. He received azithromycin empirically for atypical community-acquired pneumonia and was discharged home after a 9-day hospital stay on 2 L of oxygen, apixaban, albuterol inhaler, benzonatate, and ergocalciferol.
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis
Published in Journal of Medical Economics, 2021
William V. Padula, Shreena Malaviya, Natalie M. Reid, Benjamin G. Cohen, Francine Chingcuanco, Jeromie Ballreich, Jonothan Tierce, G. Caleb Alexander
Patients in I2 were assigned daily costs for acetaminophen and a benzonatate prescription29,31. This care pathway was initiated with the average cost of a visit to primary or urgent care provider32. They were also assigned the cost of a COVID-19 test to confirm the cause of illness32. These patients were allocated the cost of full sick leave28.